
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inflammatory microenvironment remodelling by tumour cells after radiotherapy
Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 203-217
Closed Access | Times Cited: 609
Martin McLaughlin, Emmanuel C. Patin, Malin Pedersen, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 203-217
Closed Access | Times Cited: 609
Showing 1-25 of 609 citing articles:
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1577
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1577
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 729
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 729
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 576
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 576
Immune checkpoint therapy—current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 441
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 441
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 439
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 439
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 378
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 378
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 344
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 344
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 253
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 253
Immunotherapy in colorectal cancer: current achievements and future perspective
Ahui Fan, Boda Wang, Xin Wang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 3837-3849
Open Access | Times Cited: 252
Ahui Fan, Boda Wang, Xin Wang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 3837-3849
Open Access | Times Cited: 252
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Shohei Koyama, Hiroyoshi Nishikawa
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002591-e002591
Open Access | Times Cited: 214
Shohei Koyama, Hiroyoshi Nishikawa
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002591-e002591
Open Access | Times Cited: 214
Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
Minlin Jiang, Keyi Jia, Lei Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 2983-2994
Open Access | Times Cited: 206
Minlin Jiang, Keyi Jia, Lei Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 2983-2994
Open Access | Times Cited: 206
Electromagnetic Nanomedicines for Combinational Cancer Immunotherapy
Jing Li, Yu Luo, Kanyi Pu
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 23, pp. 12682-12705
Closed Access | Times Cited: 192
Jing Li, Yu Luo, Kanyi Pu
Angewandte Chemie International Edition (2020) Vol. 60, Iss. 23, pp. 12682-12705
Closed Access | Times Cited: 192
CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 174
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 174
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control
Claire Lhuillier, Nils-Petter Rudqvist, Takahiro Yamazaki, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 5
Open Access | Times Cited: 166
Claire Lhuillier, Nils-Petter Rudqvist, Takahiro Yamazaki, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 5
Open Access | Times Cited: 166
Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 161
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 161
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
Lisa Haas, Anais Elewaut, Camille L. Gérard, et al.
Nature Cancer (2021) Vol. 2, Iss. 7, pp. 693-708
Open Access | Times Cited: 151
Lisa Haas, Anais Elewaut, Camille L. Gérard, et al.
Nature Cancer (2021) Vol. 2, Iss. 7, pp. 693-708
Open Access | Times Cited: 151
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer
Giulia Petroni, Lewis C. Cantley, Laura Santambrogio, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 2, pp. 114-131
Open Access | Times Cited: 138
Giulia Petroni, Lewis C. Cantley, Laura Santambrogio, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 2, pp. 114-131
Open Access | Times Cited: 138
Radiobiology of the FLASH effect
Anna A. Friedl, Kevin M. Prise, Karl T. Butterworth, et al.
Medical Physics (2021) Vol. 49, Iss. 3, pp. 1993-2013
Open Access | Times Cited: 131
Anna A. Friedl, Kevin M. Prise, Karl T. Butterworth, et al.
Medical Physics (2021) Vol. 49, Iss. 3, pp. 1993-2013
Open Access | Times Cited: 131
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
Sheera R. Rosenbaum, Nicole A. Wilski, Andrew E. Aplin
Cancer Discovery (2021) Vol. 11, Iss. 2, pp. 266-281
Open Access | Times Cited: 129
Sheera R. Rosenbaum, Nicole A. Wilski, Andrew E. Aplin
Cancer Discovery (2021) Vol. 11, Iss. 2, pp. 266-281
Open Access | Times Cited: 129
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
NE Donlon, Robert Power, Conall Hayes, et al.
Cancer Letters (2021) Vol. 502, pp. 84-96
Open Access | Times Cited: 129
NE Donlon, Robert Power, Conall Hayes, et al.
Cancer Letters (2021) Vol. 502, pp. 84-96
Open Access | Times Cited: 129
ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation
Yuanqin Yang, Meng Wu, Dongqing Cao, et al.
Science Advances (2021) Vol. 7, Iss. 41
Open Access | Times Cited: 123
Yuanqin Yang, Meng Wu, Dongqing Cao, et al.
Science Advances (2021) Vol. 7, Iss. 41
Open Access | Times Cited: 123
The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes
Sayali Onkar, Neil Carleton, Peter C. Lucas, et al.
Cancer Discovery (2022) Vol. 13, Iss. 1, pp. 23-40
Open Access | Times Cited: 120
Sayali Onkar, Neil Carleton, Peter C. Lucas, et al.
Cancer Discovery (2022) Vol. 13, Iss. 1, pp. 23-40
Open Access | Times Cited: 120
Nanobiomaterial-based vaccination immunotherapy of cancer
Fangmin Chen, Yingjie Wang, Jing Gao, et al.
Biomaterials (2021) Vol. 270, pp. 120709-120709
Closed Access | Times Cited: 118
Fangmin Chen, Yingjie Wang, Jing Gao, et al.
Biomaterials (2021) Vol. 270, pp. 120709-120709
Closed Access | Times Cited: 118
Delivery of STING agonists for adjuvanting subunit vaccines
Simon Van Herck, Bing Feng, Li Tang
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114020-114020
Open Access | Times Cited: 112
Simon Van Herck, Bing Feng, Li Tang
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114020-114020
Open Access | Times Cited: 112
Tailoring Aggregation Extent of Photosensitizers to Boost Phototherapy Potency for Eliciting Systemic Antitumor Immunity
Hao Zhao, Jiabao Xu, Chan Feng, et al.
Advanced Materials (2021) Vol. 34, Iss. 8
Closed Access | Times Cited: 104
Hao Zhao, Jiabao Xu, Chan Feng, et al.
Advanced Materials (2021) Vol. 34, Iss. 8
Closed Access | Times Cited: 104